PMS2 and Lynch syndrome: Thus, the two MutL homologs are partially redundant, possibly explaining the 40:1 ratio of MLH1 to PMS2 gene mutations seen in Lynch syndrome tumors (Lynch and de la Chapelle 2003; Lynch et al. 2009).